European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

hameln pharma GmbH, Hameln, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

hameln pharma GmbH
hameln pharma plus GmbH

Identification

Ut
District Court of Hanover HRB 100021
Lei
5299008X4Z3SAPOCGT28
EUID
DEP2305.HRB100021

Address

Inselstr. 1, 31787 Hameln, Germany

Corporate purpose

The distribution and trade of pharmaceuticals, remedies, cosmetic articles and related products, as well as the licensing of drug approvals, registrations, patents, trademarks and other intangible assets, as well as consulting in the pharmaceutical and related environment. Participation in other companies of the same or similar nature.

Financials

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Network

Loading network

Publications

26 Sept 2025
Wordmark: “DolAir“
24 Sept 2025
Authorized signatory (ppa): Christian Rösner
4 Feb 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023 · Shareholder (4 companies)
29 Nov 2024
No longer Authorized signatory (ppa): Sarah Pieper
11 Jul 2024
Authorized signatory (ppa): Uwe Teubert
23 May 2024
No longer Authorized signatory (ppa): Ralph Lergenmüller
5 Apr 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022 · Shareholder (4 companies)
11 Sept 2023
Authorized signatory (ppa): Ralph Lergenmüller, Sarah Pieper
9 Mar 2023
No longer Authorized signatory (ppa) (1)
31 Jan 2023
No longer Managing Director: Wolf-Ch. Kanzelmeyer
13 Jan 2023
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021 · Shareholdings (4 companies)
1 Aug 2022
No longer Authorized signatory (ppa) (1)
7 Mar 2022
Managing Director: Beate Küter
3 Mar 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020 · Shareholdings: Hameln Pharma ApS, Hameln Pharma B.V., Hameln Pharma Pty. Ltd
3 Jan 2022
Control: hameln group GmbH · Control: hameln group GmbH
8 Mar 2021
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
16 Dec 2020
Patent: New Intermediates for the Preparation of Remifentanil Hydrochloride
18 Sept 2020
Original document: “Liste der Gesellschafter“
1 Apr 2020
Managing Director: Wolf-Ch. Kanzelmeyer · Address · Share­holder agreement · Name: hameln pharma GmbH
18 Mar 2020 as hameln pharma plus GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
30 Jan 2020 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
17 Dec 2019 as hameln pharma plus GmbH
Authorized signatory (ppa): Frank Jahrand
12 Mar 2019 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
25 Sept 2018 as hameln pharma plus GmbH
Authorized signatory (ppa): Stephen Watkin
20 Jul 2018 as hameln pharma plus GmbH
Authorized signatory (ppa): Stephen Watkin
11 Jul 2018 via Hameln Pharma ApS
Founder: HPP Denmark ApS
9 Jul 2018 as hameln pharma plus GmbH
Authorized signatory (ppa) (1)
7 Mar 2018 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
1 Mar 2018 as hameln pharma plus GmbH
Authorized signatory (ppa) (1)
26 Feb 2018 via hameln group GmbH also 13/03/2017, 02/02/2017, 29/03/2016, 02/04/2015
Shareholder: hameln group GmbH
25 Aug 2017 as hameln pharma plus GmbH
Authorized signatory (ppa): Stefan Bartsch, Anja Bosbach
10 Aug 2017
Authorized signatory (ppa): Stefan Bartsch, Anja Bosbach
19 Jul 2017 as hameln pharma plus GmbH
Patent: Crystalline Forms of Trisodium Zink Diethylene Triamine Pentaacetic Acid
8 May 2017 as hameln pharma plus GmbH
No longer Authorized signatory (ppa) (1)
14 Mar 2017 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
1 Dec 2016 as hameln pharma plus GmbH
Patent: Auswahl von Sterilisationsverfahren für Tuben
11 Aug 2016 as hameln pharma plus GmbH
Authorized signatory (ppa): Uwe Hölscher
29 Mar 2016 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
12 Nov 2015 as hameln pharma plus GmbH
Patent: Auswahl von Sterilisationsverfahren für Tuben
13 Mar 2015 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013
3 Dec 2014 as hameln pharma plus GmbH
Control: hameln group GmbH · Control: hameln group GmbH
Year 2014 in Dpmap
8 patent filings: Kristalline Formen von Trinatrium-Zink-Diethylentriaminpentaessigsäure …
17 Nov 2014 as hameln pharma plus GmbH
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
9 Jul 2014 as hameln pharma plus GmbH
Patent: Synthesis of Fentanyl Analogs
12 May 2014 as hameln pharma plus GmbH
Patent: Method for Filling Syringes for Syringe Drivers
8 May 2014 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
23 May 2013 as hameln pharma plus GmbH
Patent: Crystalline Forms of Trisodium Zink Diethylene Triamine Pentaacetic Acid
15 May 2013 as hameln pharma plus GmbH
Patent: Process for Filling of Syringes for Dosing Pumps
18 Feb 2013 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
30 Dec 2011 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010
14 Jul 2011 as hameln pharma plus GmbH
Patent: Parenteral Compositions
21 Feb 2011 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
4 Mar 2010 as hameln pharma plus GmbH
Managing Director: Wolf-Ch. Kanzelmeyer · No longer Managing Director (1)
26 Feb 2010 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008
22 Feb 2010
Managing Director: Wolf-Ch. Kanzelmeyer · No longer Managing Director (1)
8 Sept 2009 as hameln pharma plus GmbH
Authorized signatory (ppa): Gerhard Ewald · No longer Authorized signatory (ppa) (1)
31 Aug 2009
Authorized signatory (ppa): Gerhard Ewald · No longer Authorized signatory (ppa) (1)
30 Mar 2009 as hameln pharma plus GmbH
Share­holder agreement · The distribution and trade of medicinal products, remedies, cosmetic articles and related products, as well as the licensing of drug approvals, registrations, patents …
26 Feb 2009 as hameln pharma plus GmbH
Original document: “Liste der Gesellschafter“
26 Feb 2009 as hameln pharma plus GmbH
Original document: “Liste der Gesellschafter“
26 Feb 2009 as hameln pharma plus GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
25 Feb 2009 as hameln pharma plus GmbH
Original document: “Liste der Gesellschafter“
25 Feb 2009 as hameln pharma plus GmbH
Original document: “Liste der Gesellschafter“
11 Dec 2008 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007
24 Nov 2008 as hameln pharma plus GmbH
Managing Director (1) · No longer Managing Director (1)
8 Apr 2008 as hameln pharma plus GmbH
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006
18 Apr 2007 as hameln pharma plus GmbH
No longer managing directors: N.N., apotheker, Hameln
5 Mar 2007 as hameln pharma plus GmbH
Original document: “Liste der Gesellschafter“
27 Feb 2007 as hameln pharma plus GmbH
No longer Authorized signatory (ppa) (1)
20 Nov 2006
Authorized signatory (ppa) (2)
29 May 2006 as hameln pharma plus GmbH
Reg­is­tra­tion · MD (1) · ppa (1) · Control · Control · Capital: €30,000 · Seat: Hameln · Legal form: GmbH · Name: hameln pharma plus GmbH · Proxy policy …
There are no publications matching your search.

Mentions

1 Aug 2008 in Wzfma also 17/07/2008, 30/09/2005
Shareholding: hameln pharma handelsgesellschaft mbH
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "hameln pharma GmbH, Hameln, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.